Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : Announces Collaboration to Provide Access to Deep Learning Tools for Discovery and Targeted Proteomics

share with twitter share with LinkedIn share with facebook
05/27/2020 | 09:46am EDT

SAN JOSE - Thermo Fisher Scientific, the world leader in serving science, and MSAID GmbH, a software company transforming proteomics with deep learning, announce an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID's Prosit-derived framework widely accessible to proteomics laboratories.

The availability of deep learning tools will enable improved confidence in proteomics research results, primarily in the areas of protein profiling using label-free or tandem mass tag (TMT)-based quantification, and a variety of new applications.

The new algorithm allows gains in confidence and reproducibility and will be released as part of Thermo Fisher's newest Thermo Scientific Proteome Discoverer 2.5 software release. Users can now access deep-learning-based prediction of tandem mass spectra, allowing for the formation of entire spectral libraries on demand and facilitating the identification of peptides with up to 10 times higher confidence and the extraction of more identifications from proteomics datasets via intensity-based rescoring. In combination with Thermo Scientific Orbitrap technology, the new algorithm enables emerging applications, such as immunopeptidomics and metaproteomics, for which traditional database search and statistical approaches are often ineffective.

'Increasing the confidence of protein and peptide identifications is a growing need, given that a false discovery rate of even 1% means that 1,000 out of every 100,000 peptides might be incorrectly assigned,' said Mark Sanders, director of life science mass spectrometry software, Thermo Fisher Scientific. 'Applying deep learning tools enables data-independent analysis of proteomics samples with higher confidence and reproducibility, and, when used with Orbitrap technology, reduces the false discovery rate 10-fold, to merely 100 out of every 100,000 peptides.'

Martin Frejno, chief executive officer, MSAID GmbH, said, 'At MSAID, we reinvent the way proteomic data is acquired and analyzed by using state-of-the-art deep learning. Through our collaboration with Thermo Fisher Scientific, we can bring this technological revolution to laboratories around the world and empower the scientific community to gain exceptional insight into new and existing data.'

Thermo Fisher Scientific will showcase outcomes of the collaboration and its newest products and software solutions in a company-hosted virtual event, vLC-MS.com, from May 26-28, 2020, and at the American Society for Mass Spectrometry (ASMS) Reboot Program, from June 1-12, 2020.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Contact:

Laura Bright

Tel: +1 562-335-8318

Email: laura.bright@thermofisher.com

(C) 2020 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
Latest news on THERMO FISHER SCIENTIFIC
07/09THERMO FISHER SCIENTIFIC : Declares Quarterly Dividend
PR
07/07THERMO FISHER SCIENTIFIC : Provides Update to Second Quarter Outlook and Will Ho..
AQ
07/06Thermo Fisher, Uber rise; Bellus, Dominion fall
AQ
07/06THERMO FISHER SCIENTIFIC : Says 2Q Sales Boosted by Pandemic Response
DJ
07/06THERMO FISHER SCIENTIFIC INC. : Results of Operations and Financial Condition, F..
AQ
07/06THERMO FISHER SCIENTIFIC : Provides Update to Second Quarter Outlook and Will Ho..
PR
07/02THERMO FISHER SCIENTIFIC : Launches New MAS Omni Infectious Disease Quality Cont..
AQ
06/23THERMO FISHER SCIENTIFIC : Schrodinger in Collaboration with Thermo Fisher Scien..
DJ
06/17THERMO FISHER SCIENTIFIC : iSPA Workflow Helps Pharmaceutical Companies Bring Ne..
AQ
06/12THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
More news
Financials (USD)
Sales 2020 27 701 M - -
Net income 2020 3 528 M - -
Net Debt 2020 12 387 M - -
P/E ratio 2020 42,7x
Yield 2020 0,22%
Capitalization 150 B 150 B -
EV / Sales 2019
EV / Sales 2020 5,85x
Nbr of Employees 75 000
Free-Float 90,5%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 378,12 $
Last Close Price 378,93 $
Spread / Highest target 13,5%
Spread / Average Target -0,21%
Spread / Lowest Target -28,5%
EPS Revisions
Managers
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Scott M. Sperling Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
THERMO FISHER SCIENTIFIC17.76%151 096
DANAHER CORPORATION19.67%129 858
INTUITIVE SURGICAL, INC.-2.58%67 157
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.81.14%55 340
ILLUMINA, INC.11.61%54 427
BOSTON SCIENTIFIC CORPORATION-23.31%49 416